SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

DYAI - Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately

DYAI - Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.